SCHEMBL30983891

SCHEMBL30983891

Cc1cc(O)ccc1-c1nc2c(OC(C)C)ncnc2n1Cc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DAPK1 P53355 3/20 0.43
▸ PIK3CD O00329 2/20 0.37
▸ ABL1 P00519 1/20 0.37
▸ EGFR P00533 1/20 0.37
▸ HCK P08631 1/20 0.37
▸ SRC P12931 1/20 0.37
▸ KDR P35968 1/20 0.37
▸ PIK3CA P42336 1/20 0.37
▸ PIK3CB P42338 1/20 0.37
▸ MTOR P42345 1/20 0.37
▸ PIK3CG P48736 1/20 0.37
▸ EPHB4 P54760 1/20 0.37
▸ PRKDC P78527 1/20 0.37
▸ PI4KB Q9UBF8 1/20 0.37
▸ ADORA2A P29274 1/20 0.36
▸ ADORA1 P30542 1/20 0.36
▸ MAPK1 P28482 3/20 0.35
▸ LMNA P02545 2/20 0.35
▸ TSHR P16473 2/20 0.35
▸ HTT P42858 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31321967 0.86 DAPK1 (0.47) DAPK1PIK3CDMTORADORA2AADORA1
SCHEMBL30983966 0.83 MEN1 (0.46) PIK3CDABL1EGFRHCKSRC
SCHEMBL30983927 0.80 LTA4H (0.42) MAPK1ALDH1A1MEN1KMT2AKDM4E
SCHEMBL30983877 0.79 LTA4H (0.42) ALDH1A1MEN1KMT2AKDM4E
SCHEMBL30983532 0.78 MAOB (0.44) SRCKDRMAPK1ALDH1A1MEN1
SCHEMBL30983776 0.76 PIK3CD (0.40) DAPK1PIK3CDADORA2AADORA1MEN1
SCHEMBL30983513 0.75 GPR4 (0.42) PIK3CDMAPK1ALDH1A1MEN1KMT2A
SCHEMBL28939435 0.71 DAPK1 (0.45) DAPK1PIK3CDKDRADORA2AADORA1
SCHEMBL31321959 0.70 TLR7 (0.47) PIK3CD
SCHEMBL30983903 0.69 PIK3CD (0.42) DAPK1PIK3CDADORA2AADORA1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4689155-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS Astrazeneca AB (SE) 2026-02-11 — — EP disclosed
EP-4630410-A1 POLQ INHIBITORS Astrazeneca AB (SE) 2025-10-15 — — EP disclosed
WO-2024201368-A1 USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS ASTRAZENECA AB (SE) 2024-10-03 — — WO disclosed
WO-2024121753-A1 POLQ INHIBITORS ASTRAZENECA AB (SE) 2024-06-13 — — WO disclosed
Send feedback